Zhejiang Tailin Bioengineering Stock Revenue
| 300813 Stock | 17.68 0.53 2.91% |
Zhejiang Tailin Bioengineering fundamentals help investors to digest information that contributes to Zhejiang Tailin's financial success or failures. It also enables traders to predict the movement of Zhejiang Stock. The fundamental analysis module provides a way to measure Zhejiang Tailin's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zhejiang Tailin stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 269.9 M | 236.6 M |
Zhejiang | Revenue |
Zhejiang Tailin Bioengineering Company Revenue Analysis
Zhejiang Tailin's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Zhejiang Tailin Revenue | 269.86 M |
Most of Zhejiang Tailin's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zhejiang Tailin Bioengineering is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Zhejiang
Projected quarterly revenue analysis of Zhejiang Tailin Bioe provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Zhejiang Tailin match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Zhejiang Tailin's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Zhejiang Total Revenue
Total Revenue |
|
Based on the latest financial disclosure, Zhejiang Tailin Bioengineering reported 269.86 M of revenue. This is 96.46% lower than that of the Health Care Equipment & Supplies sector and 89.42% lower than that of the Health Care industry. The revenue for all China stocks is 97.14% higher than that of the company.
Zhejiang Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zhejiang Tailin's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zhejiang Tailin could also be used in its relative valuation, which is a method of valuing Zhejiang Tailin by comparing valuation metrics of similar companies.Zhejiang Tailin is currently under evaluation in revenue category among its peers.
Zhejiang Fundamentals
| Return On Equity | 0.0125 | ||||
| Return On Asset | 0.0025 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 2.15 B | ||||
| Shares Outstanding | 121.2 M | ||||
| Shares Owned By Insiders | 66.68 % | ||||
| Shares Owned By Institutions | 0.24 % | ||||
| Price To Book | 3.27 X | ||||
| Price To Sales | 7.04 X | ||||
| Revenue | 269.86 M | ||||
| Gross Profit | 171.43 M | ||||
| EBITDA | 16.15 M | ||||
| Net Income | 19.67 M | ||||
| Total Debt | 323.27 M | ||||
| Book Value Per Share | 6.00 X | ||||
| Cash Flow From Operations | 1.93 M | ||||
| Earnings Per Share | 0.08 X | ||||
| Number Of Employees | 888 | ||||
| Beta | 1.19 | ||||
| Market Capitalization | 2.18 B | ||||
| Total Asset | 973.51 M | ||||
| Retained Earnings | 248.58 M | ||||
| Working Capital | 476.94 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 973.51 M | ||||
| Last Dividend Paid | 0.1 |
About Zhejiang Tailin Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zhejiang Tailin Bioengineering's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zhejiang Tailin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zhejiang Tailin Bioengineering based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Zhejiang Stock
Zhejiang Tailin financial ratios help investors to determine whether Zhejiang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhejiang with respect to the benefits of owning Zhejiang Tailin security.